Nuno Cerveira

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

ATG16L1 and OPTN as a novel prognostic gene expression signature in acute myeloid leukemia survival.

ATG16L1 and OPTN as a novel prognostic gene expression signature in acute myeloid leukemia survival.

Journal: Frontiers in oncology

Published: January 09, 2026

Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patients.

Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patients.

Journal: Genes, chromosomes & cancer

Published: March 28, 2023

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy.

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy.

Journal: Leukemia

Published: March 28, 2022

Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.

Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.

Journal: Leukemia

Published: March 05, 2022

When to Stop TKIs in Patients with Chronic Myeloid Leukemia and How to Follow Them Subsequently.

When to Stop TKIs in Patients with Chronic Myeloid Leukemia and How to Follow Them Subsequently.

Journal: Current treatment options in oncology

Published: March 16, 2021

Negative MR4·0 chronic myeloid leukaemia and its possible implications for treatment-free remission.

Negative MR4·0 chronic myeloid leukaemia and its possible implications for treatment-free remission.

Journal: British journal of haematology

Published: March 20, 2019

Recommendations from a Portuguese Expert Group for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients in Clinical Practice.

Recommendations from a Portuguese Expert Group for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients in Clinical Practice.

Journal: Acta medica portuguesa

Published: January 17, 2019

Evidence-Based Criteria for Tyrosine Kinase Inhibitor Interruption in Pregnancy.

Evidence-Based Criteria for Tyrosine Kinase Inhibitor Interruption in Pregnancy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 14, 2018

Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution.

Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution.

Journal: BMC cancer

Published: July 12, 2018

Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report.

Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report.

Journal: BMC cancer

Published: June 15, 2018

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale.

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale.

Journal: Leukemia

Published: March 22, 2016

Diagnosis, complications and management of chronic neutrophilic leukaemia: A case report.

Diagnosis, complications and management of chronic neutrophilic leukaemia: A case report.

Journal: Oncology letters

Published: July 02, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026